| Literature DB >> 30513932 |
Kuan Y Chang1, I-Wen Wu2, Bo-Ruei Huang3, Jih-Gau Juang4, Jia-Chyi Wu5, Su-Wei Chang6,7, Chung Cheng Chang8.
Abstract
To determine the relationships between exposure to environmental contaminants in water and chronic kidney disease (CKD), we investigated the associations of 61 water attributes with the prevalence of CKD and End-Stage Renal Disease (ESRD) using data from 2005 to 2011 from all 22 counties and cities in the main island of Taiwan. We acquired patient information from the Taiwan Longitudinal Health Insurance Database to calculate the age-standardized CKD and ESRD prevalence rates and linked the patients' residences to the water quality monitoring data, which were sampled periodically for a total of over 45,000 observations obtained from the Taiwan Environmental Water Quality Information Database. The association analysis adjusting for gender, age, and annual effects showed that the zinc (Zn), ammonia, chemical oxygen demand (COD), and dissolved oxygen in rivers were weakly correlated with CKD (τ = 0.268/0.250/0.238/-0.267, p = 6.01×10-6/2.52×10-5/6.05×10-5/3.30×10-5, respectively), but none for ESRD. The importances of Zn and COD in rivers were also demonstrated in a CKD regression model. Moreover, an unusually high CKD prevalence was related to arsenic contamination in groundwater. A further prospective cohort study would improve our understanding of what level of environmental water with risky properties could affect the development of CKD.Entities:
Keywords: ammonia; arsenic; chemical oxygen demand; chronic kidney disease; dissolved oxygen; end-stage renal disease; water contaminants; zinc
Mesh:
Substances:
Year: 2018 PMID: 30513932 PMCID: PMC6313415 DOI: 10.3390/ijerph15122726
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1The 22 counties and cities in Taiwan. The map colors have no special meanings.
ICD-9 codes for CKD and ESRD.
| Disease | ICD-9 Codes |
|---|---|
| CKD | 250.4, 274.1, 283.11, 403.1, 404.2, 404.3, 440.1, 442.1, |
| 447.3, 572.3, 580–588, 593, 642.1, 646.2, 753.1 | |
| ESRD | 585 and associates |
Description of ICD-9 codes.
| ICD-9 Codes | Disease Description |
|---|---|
| 250.4 | Diabetic Nephropathy |
| 274.1 | Gouty Nephropathy |
| 283.11 | Hemolytic Uremic Syndrome |
| 403.1 | Hypertensive Nephropathy |
| 404.2 | Malignant hypertension with renal and cardiac complication |
| 404.2 | Malignant hypertension with renal and cardiac failure |
| 440.1 | Renovascular atherosclerotic disease |
| 442.1 | Aneurysm of renovascular system |
| 447.3 | Renovascular hyperplasia |
| 572.3 | Renovascular hypertension |
| 580 | Acute glomerulonephritis |
| 581 | Nephrotic syndrome |
| 582 | Chronic glomerulonephritis |
| 583 | Nephritis and renal disease |
| 584 | Acute kidney failure |
| 585 | Chronic kidney failure |
| 586 | Kidney failure |
| 587 | Renal sclerosis |
| 588 | Disease complicated by renal failure |
| 593 | Renal and ureter disease |
| 642.1 | Gestational, pregnancy related renal disease |
| 646.2 | Gestational, pregnancy related renal disease |
| 753.1 | Polycystic kidney disease |
The baseline characteristics of the study population.
| Year | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
|---|---|---|---|---|---|---|---|
| Total population, | 1,075,535 | 1,074,803 | 1,070,511 | 1,065,938 | 1,061,195 | 1,056,549 | 1,051,921 |
| Age (mean ± SD) | 36.4 ± 23.3 | 37.3 ± 23.4 | 38.2 ± 23.4 | 39.2 ± 23.4 | 40.1 ± 23.5 | 41.0 ± 23.5 | 41.9 ± 23.5 |
| Age group | |||||||
| <40 | 59.53% | 58.30% | 56.95% | 55.58% | 54.20% | 52.77% | 51.39% |
| 40–49 | 15.84% | 15.94% | 16.12% | 16.31% | 16.42% | 16.57% | 16.67% |
| 50–59 | 11.05% | 11.89% | 12.59% | 13.17% | 13.75% | 14.29% | 14.65% |
| 60–69 | 6.66% | 6.61% | 6.73% | 6.98% | 7.30% | 7.63% | 8.17% |
| 70–79 | 4.69% | 4.80% | 4.93% | 5.03% | 5.15% | 5.29% | 5.43% |
| >80 | 2.24% | 2.46% | 2.69% | 2.93% | 3.18% | 3.45% | 3.69% |
| Male | 48.60% | 48.53% | 48.45% | 48.37% | 48.29% | 48.21% | 48.11% |
| CKD prevalence | 4.00% | 4.24% | 4.49% | 4.73% | 4.97% | 5.21% | 5.53% |
| ESRD prevalence | 0.20% | 0.21% | 0.23% | 0.24% | 0.26% | 0.27% | 0.28% |
| Comorbidity | |||||||
| Diabetes | 6.40% | 7.00% | 7.20% | 8.20% | 8.90% | 9.60% | 10.30% |
| Hypertension | 11.70% | 12.70% | 13.80% | 14.80% | 15.80% | 16.80% | 17.80% |
| Hyperlipidemia | 7.50% | 8.50% | 9.61% | 10.70% | 11.81% | 12.90% | 14.00% |
CKD: chronic kidney disease; ESRD: end-stage renal disease.
The correlation between water attribute and age-standardized CKD prevalence rate, adjusting for gender, age, and annual effects (2005–2011).
| Substance | Groundwater | Reservoir | River | |||
|---|---|---|---|---|---|---|
|
|
|
| ||||
|
| ||||||
| Ag | - | - | −0.088 | 0.139 | ||
| As | 0.140 | 0.018 | - | 0.074 | 0.213 | |
| Ca | 0.007 | 0.902 | - | - | ||
| Cd | 0.089 | 0.132 | - | −0.038 | 0.520 | |
| Cl | −0.007 | 0.912 | - | - | ||
| Cr | −0.072 | 0.227 | - | −0.009 | 0.873 | |
| Cu | −0.057 | 0.335 | - | 0.022 | 0.714 | |
| Fe | −0.091 | 0.126 | - | - | ||
| Hg | - | - | −0.017 | 0.779 | ||
| K | 0.005 | 0.933 | - | - | ||
| Mg | 0.044 | 0.457 | - | - | ||
| Mn | −0.028 | 0.636 | - | 0.032 | 0.594 | |
| Na | 0.070 | 0.236 | - | - | ||
| NH3-N | 0.030 | 0.613 | −0.077 | 0.282 | 0.250 ** | 2.52 × 10−5 ** |
| NO2-N | - | −0.073 | 0.363 | 0.211 * | 3.79 × 10−4 * | |
| NO3-N | −0.180 | 0.002 | 0.078 | 0.272 | 0.191 | 0.001 |
| Pb | −0.034 | 0.568 | - | 0.059 | 0.318 | |
| Se | - | - | −0.061 | 0.383 | ||
| | −0.010 | 0.869 | - | - | ||
| Zn | −0.047 | 0.426 | - | 0.268 ** | 6.01 × 10−6 ** | |
|
| ||||||
| Alk | 0.090 | 0.128 | 0.266 * | 1.89 × 10−4 * | - | |
| BOD | - | - | 0.222 * | 1.84 × 10−4 * | ||
| Chl-A | - | 0.021 | 0.773 | - | ||
| COD | - | 0.032 | 0.648 | 0.238 ** | 6.05 × 10−5 ** | |
| Coliform | - | - | 0.148 | 0.013 | ||
| DO | - | 0.031 | 0.687 | −0.267 ** | 3.30 × 10−5 ** | |
| EC | 0.062 | 0.292 | 0.159 | 0.026 | −0.048 | 0.416 |
| pH | 0.125 | 0.035 | 0.015 | 0.833 | −0.194 | 0.001 |
| SD | - | −0.088 | 0.276 | - | ||
| SS | - | 0.197 | 0.006 | 0.022 | 0.706 | |
| TB | - | 0.167 | 0.019 | - | ||
| TDS | 0.051 | 0.389 | - | - | ||
| TH | 0.019 | 0.745 | 0.174 | 0.014 | - | |
| TKN | - | - | 0.235 | 0.044 | ||
| TOC | 0.031 | 0.597 | 0.035 | 0.627 | 0.181 | 0.002 |
| WT | 0.130 | 0.028 | 0.036 | 0.618 | 0.143 | 0.016 |
Significance levels of the Bonferroni–Holm test: ** ≤ 0.01, * ≤ 0.05. Abbreviations: Alk: Alkalinity; BOD: Biochemical Oxygen Demand; Chl-A: Chlorophyll-A; COD: Chemical Oxygen Demand; DO: Dissolved Oxygen; EC: Electrical conductivity; SD: Secchi Depth (Transparency); SS: Suspended Solids; TB: Turbidity; TDS: Total Dissolved Solids; TH: Total Hardness; TKN: Total Kjeldahl nitrogen; TOC: Total Organic Carbon; WT: Water Temperature.
The correlation between water attribute and age-standardized ESRD prevalence rate adjusting for gender, age, and annual effects (2005–2011).
| Substance | Groundwater | Reservoir | River | |||
|---|---|---|---|---|---|---|
|
|
|
| ||||
|
| ||||||
| Ag | - | - | −0.034 | 0.568 | ||
| As | 0.106 | 0.073 | - | −0.017 | 0.777 | |
| Ca | 0.007 | 0.900 | - | - | ||
| Cd | 0.165 | 0.005 | - | 0.021 | 0.718 | |
| Cl | −0.058 | 0.379 | - | - | ||
| Cr | −0.043 | 0.472 | - | −0.009 | 0.878 | |
| Cu | −0.061 | 0.300 | - | 0.004 | 0.949 | |
| Fe | −0.079 | 0.182 | - | - | ||
| Hg | - | - | −0.080 | 0.179 | ||
| K | −0.112 | 0.058 | - | - | ||
| Mg | −0.097 | 0.100 | - | - | ||
| Mn | −0.016 | 0.793 | - | 0.074 | 0.214 | |
| Na | −0.059 | 0.319 | - | - | ||
| NH3-N | 0.018 | 0.764 | −0.176 | 0.013 | 0.094 | 0.111 |
| NO2-N | - | −0.064 | 0.426 | 0.109 | 0.067 | |
| NO3-N | −0.113 | 0.057 | 0.055 | 0.441 | 0.086 | 0.149 |
| Pb | 0.030 | 0.616 | - | 0.046 | 0.438 | |
| Se | - | - | −0.012 | 0.867 | ||
| | −0.103 | 0.084 | - | - | ||
| Zn | −0.135 | 0.023 | - | 0.167 | 0.005 | |
|
| ||||||
| Alk | 0.005 | 0.932 | −0.008 | 0.914 | - | |
| BOD | - | - | 0.073 | 0.215 | ||
| Chl-A | - | −0.017 | 0.807 | - | ||
| COD | - | −0.056 | 0.429 | 0.138 | 0.020 | |
| Coliform | - | - | 0.018 | 0.762 | ||
| DO | - | 0.052 | 0.501 | −0.056 | 0.388 | |
| EC | −0.033 | 0.577 | −0.096 | 0.178 | −0.081 | 0.172 |
| pH | 0.100 | 0.090 | −0.134 | 0.060 | −0.132 | 0.026 |
| SD | - | 0.047 | 0.560 | - | ||
| SS | - | −0.021 | 0.768 | −0.044 | 0.459 | |
| TB | - | 0.002 | 0.973 | - | ||
| TDS | −0.021 | 0.728 | - | - | ||
| TH | −0.018 | 0.766 | −0.088 | 0.218 | - | |
| TKN | - | - | −0.047 | 0.685 | ||
| TOC | −0.046 | 0.439 | −0.050 | 0.486 | 0.077 | 0.077 |
| WT | 0.010 | 0.865 | 0.014 | 0.845 | 0.054 | 0.364 |
None passed the Bonferroni–Holm test. Abbreviations: Alk: Alkalinity; BOD: Biochemical Oxygen Demand; Chl-A: Chlorophyll-A; COD: Chemical Oxygen Demand; DO: Dissolved Oxygen; EC: Electrical conductivity; SD: Secchi Depth (Transparency); SS: Suspended Solids; TB: Turbidity; TDS: Total Dissolved Solids; TH: Total Hardness; TKN: Total Kjeldahl nitrogen; TOC: Total Organic Carbon; WT: Water Temperature.
Figure 2The relationship between arsenic in groundwater and age-standardized chronic kidney disease (CKD)/ end-stage renal disease (ESRD) prevalence rates (2005–2011): (a) the CKD prevalence rate in groundwater and (b) the ESRD prevalence rate in groundwater. The influential observations are labeled by the color-coded year symbols ‘×’.
The generalized additive models (GAMs) of CKD prevalence in Taiwan using selected river attributes.
| Model | AIC | ΔAIC | R2 | DE (%) |
|---|---|---|---|---|
| sex + age + year | −955.0 | 32.6 | 0.742 | 70.7 |
| sex + age + year + COD | −972.2 | 15.4 | 0.769 | 75.0 |
| sex + age + year + DO | −844.2 | 143.4 | 0.788 | 77.2 |
| sex + age + year + NH3 | −973.0 | 14.6 | 0.772 | 75.6 |
| sex + age + year + Zn | −985.2 | 2.4 | 0.821 | 78.2 |
| sex + age + year + Zn + COD | −987.6 | 0 | 0.820 | 78.8 |
| sex + age + year + Zn + DO | −846.5 | 141.1 | 0.805 | 78.2 |
| sex + age + year + Zn + NH3 | −983.9 | 3.7 | 0.817 | 78.5 |
| sex + age + year + Zn + COD + NH3 | −986.3 | 1.3 | 0.818 | 78.9 |
| sex + age + year + Zn + COD + DO + NH3 | −850.3 | 137.3 | 0.809 | 80.1 |
ΔAICi = AICi − AICmin; Abbreviations: AlC: Akaike Information Criterion; COD: Chemical Oxygen Demand; DE: Deviance explained; DO: Dissolved Oxygen.